Please login to the form below

Not currently logged in
Email:
Password:

GSK closes site earlier than planned

GlaxoSmithKline has brought forward the closure of its Dartford plant as planning permission is sought for the site

GlaxoSmithKline (GSK) is to close its Dartford, UK, plant in six months, earlier than originally planned.

Since the plant's closure was announced in November 2008, about 450 staff have been made redundant by the drug manufacturer. The remaining 180 workers will all be laid off by October, with 60 due to leave this month.

The announcement brings forward the original date for closure, which was the end of 2012.

An outline planning application for between 950 and 1,050 new homes was placed with Dartford Borough Council on Monday. The application is also for between 2,500 and 5,000sq m of commercial space, which could create between 80 and 150 jobs.

The move will end more than 120 years of pharmaceutical production at East Hill, Dartford.

The announcement comes as Novartis said it would cut over 500 jobs at its plant in Horsham. Pfizer has also recently announced it is to cut around 2,400 jobs with the closure of its facility in Sandwich, Kent.

17th March 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....